Last reviewed · How we verify

NCT07193368: HYDRO-KNEE

Intra-Articular Polyacrylamide Hydrogel Injections Improve Pain and Function in Knee Osteoarthritis

Completed Last updated 25 September 2025
What this trial tests

trial testing Polyacrylamide hydrogel 2.5% intra-articular injection in Knee Osteoarthritis in 387 participants. Completed in 24 June 2025.

Timeline
11 February 2023
Primary endpoint
24 June 2025
24 June 2025

Quick facts

Lead sponsorFeza Korkusuz MD
StatusCompleted
Study typeOBSERVATIONAL
Enrollment387
Start date11 February 2023
Primary completion24 June 2025
Estimated completion24 June 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Feza Korkusuz MD — full company profile →

Who can join

40 and older, any sex, with Knee Osteoarthritis or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to evaluate the effects of intra-articular injections of polyacrylamide hydrogel (Arthrosamid®) in patients with knee osteoarthritis. A total of 387 patients (593 knees) were treated across three medical centers in Türkiye. The purpose of the study is to determine whether this injection can reduce knee pain and improve physical function in everyday life. Pain is being measured using a Visual Analogue Scale (VAS), and function is being assessed with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07193368.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing